KR100419185B1 - Healty food composition for obesity control - Google Patents
Healty food composition for obesity control Download PDFInfo
- Publication number
- KR100419185B1 KR100419185B1 KR10-2000-0038820A KR20000038820A KR100419185B1 KR 100419185 B1 KR100419185 B1 KR 100419185B1 KR 20000038820 A KR20000038820 A KR 20000038820A KR 100419185 B1 KR100419185 B1 KR 100419185B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- obesity
- food
- control
- bean
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title claims abstract description 58
- 235000020824 obesity Nutrition 0.000 title claims abstract description 58
- 235000013305 food Nutrition 0.000 title claims description 22
- 239000000203 mixture Substances 0.000 title claims description 20
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 12
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 9
- 229940010454 licorice Drugs 0.000 claims abstract description 9
- 240000004922 Vigna radiata Species 0.000 claims abstract description 7
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 7
- 240000007185 Albizia julibrissin Species 0.000 claims abstract description 6
- 235000011468 Albizia julibrissin Nutrition 0.000 claims abstract description 6
- 241000288961 Saguinus imperator Species 0.000 claims abstract description 6
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 6
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004006 olive oil Substances 0.000 claims abstract description 6
- 235000008390 olive oil Nutrition 0.000 claims abstract description 6
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 5
- 244000080767 Areca catechu Species 0.000 claims abstract description 5
- 239000000454 talc Substances 0.000 claims abstract description 5
- 229910052623 talc Inorganic materials 0.000 claims abstract description 5
- 235000013527 bean curd Nutrition 0.000 claims abstract description 3
- 239000003610 charcoal Substances 0.000 claims abstract description 3
- 231100000614 poison Toxicity 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- 241001107116 Castanospermum australe Species 0.000 claims description 3
- 235000021279 black bean Nutrition 0.000 claims description 3
- 230000007096 poisonous effect Effects 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 2
- 240000004160 Capsicum annuum Species 0.000 claims 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims 1
- 235000007862 Capsicum baccatum Nutrition 0.000 claims 1
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 239000001728 capsicum frutescens Substances 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 16
- 206010033307 Overweight Diseases 0.000 abstract description 14
- 238000011282 treatment Methods 0.000 abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 11
- 206010020772 Hypertension Diseases 0.000 abstract description 5
- 201000006549 dyspepsia Diseases 0.000 abstract description 5
- 206010010774 Constipation Diseases 0.000 abstract description 3
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract description 3
- 208000000689 peptic esophagitis Diseases 0.000 abstract description 3
- 239000002386 air freshener Substances 0.000 abstract 1
- QUQFTIVBFKLPCL-UHFFFAOYSA-L copper;2-amino-3-[(2-amino-2-carboxylatoethyl)disulfanyl]propanoate Chemical compound [Cu+2].[O-]C(=O)C(N)CSSCC(N)C([O-])=O QUQFTIVBFKLPCL-UHFFFAOYSA-L 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 29
- 229940079593 drug Drugs 0.000 description 14
- 230000033001 locomotion Effects 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 11
- 238000002560 therapeutic procedure Methods 0.000 description 11
- 230000004580 weight loss Effects 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 10
- 239000002253 acid Substances 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 208000017169 kidney disease Diseases 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002023 wood Substances 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000002485 urinary effect Effects 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 230000004584 weight gain Effects 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- 229930013930 alkaloid Natural products 0.000 description 4
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 4
- 235000019577 caloric intake Nutrition 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 235000012041 food component Nutrition 0.000 description 4
- 239000005417 food ingredient Substances 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 208000012113 pregnancy disease Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 210000000579 abdominal fat Anatomy 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000004296 neuralgia Diseases 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- DNJFTXKSFAMXQF-UHFFFAOYSA-N Arecaidine Chemical compound CN1CCC=C(C(O)=O)C1 DNJFTXKSFAMXQF-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 238000008214 LDL Cholesterol Methods 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- KUECBJOPWMRHEX-CQSZACIVSA-N Tuduranine Chemical compound C1C2=CC=C(O)C=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1NCC3 KUECBJOPWMRHEX-CQSZACIVSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 238000011325 biochemical measurement Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- UWHUTZOCTZJUKC-JKSUJKDBSA-N brazilin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-JKSUJKDBSA-N 0.000 description 2
- UWHUTZOCTZJUKC-CVEARBPZSA-N brazilin Natural products C12=CC(O)=C(O)C=C2C[C@@]2(O)[C@@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-CVEARBPZSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229930013032 isoflavonoid Natural products 0.000 description 2
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 2
- 235000012891 isoflavonoids Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229930193551 sterin Natural products 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N 2,3-di(octadeca-9,12-dienoyloxy)propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- WCXZTKJFWJFMJG-UHFFFAOYSA-N 24-Hydroxy-3-oxoolean-12en-28-oic-saeure Natural products C1CC(=O)C(C)(CO)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C WCXZTKJFWJFMJG-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- UWHUTZOCTZJUKC-UHFFFAOYSA-N 7,11b-dihydro-6H-indeno[2,1-c][1]benzopyran-3,6a,9,10-tetrol Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000838298 Aralia continentalis Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- POIRVLZGTSWEMG-UHFFFAOYSA-N Magnoflorin Natural products N1CCC2=CC(OC)=C(O)C3=C2C1CC1=CC=C(OC)C(O)=C13 POIRVLZGTSWEMG-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- 241000795633 Olea <sea slug> Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 1
- 244000100170 Phaseolus lunatus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008180 Piper betle Nutrition 0.000 description 1
- 240000008154 Piper betle Species 0.000 description 1
- 241001127637 Plantago Species 0.000 description 1
- 241001499733 Plantago asiatica Species 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000021129 Postpartum disease Diseases 0.000 description 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 1
- 244000086363 Pterocarpus indicus Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000305267 Quercus macrolepis Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 240000008301 Rhynchosia minima Species 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241001643409 Sinomenium acutum Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- KUECBJOPWMRHEX-UHFFFAOYSA-N Tuduranine Natural products C1C2=CC=C(O)C=C2C2=C(OC)C(OC)=CC3=C2C1NCC3 KUECBJOPWMRHEX-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000002956 ash Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021331 green beans Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- PGOYMURMZNDHNS-MYPRUECHSA-N hederagenin Chemical compound C1C[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PGOYMURMZNDHNS-MYPRUECHSA-N 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000000393 hypersympathetic effect Effects 0.000 description 1
- 206010021654 increased appetite Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical compound C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 description 1
- 235000002324 isoflavanes Nutrition 0.000 description 1
- OWDQPILTDJLGCN-UHFFFAOYSA-N isosinomenine Natural products C1C2=CC=C(OC)C(O)=C2C23C=C(OC)C(=O)CC3C1N(C)CC2 OWDQPILTDJLGCN-UHFFFAOYSA-N 0.000 description 1
- 235000021332 kidney beans Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004037 social stress Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 비만조절용 건강보조식품 조성물에 관한 것으로, 자귀나무 2∼8 중량%, 녹두 1∼7 중량%, 소방목 2∼8 중량%, 타마린 4∼10 중량%, 야흑두 4∼10 중량%, 넝쿨콩 4∼10 중량%, 야두 4∼10 중량%, 방기 2∼8 중량%, 저령 3∼9 중량%, 야소두 3∼9 중량%, 활석 0∼4 중량%, 동규자 2∼8 중량%, 야홍두 2∼8중량%, 독활 2∼8 중량%, 차전자 0∼5 중량%, 감초 1∼7 중량%, 빈랑 2∼8 중량%, 목통 2∼8 중량%, 상기생 2∼8 중량%, 올리브유 0∼5 중량%로 구성되어 비만 및 과체중의 조절 이외에도 역류성식도염, 소화불량, 변비, 고혈압의 치료에 뛰어난 효과가 있다.The present invention relates to a dietary supplement for the control of obesity, 2-8% by weight of silk tree, 1-7% by weight of mung bean, 2-8% by weight of firewood, 4-10% by weight of tamarin, 4-10% by weight of dark bean, 4-10 wt% of vine beans, 4-10 wt% of bean curd, 2-8 wt% of air freshener, age 3-9 wt%, 3-9 wt% of curd beans, 0-4 wt% of talc, 2-8 wt% of copper , 2-8% by weight of mung bean, 2-8% by weight, 0-5% by weight of charcoal, 1-7% by weight licorice, 2-8% by weight of betel nut, 2-8% by weight of neck, 2-8% %, Olive oil of 0 to 5% by weight, in addition to the control of obesity and overweight, has excellent effects in the treatment of reflux esophagitis, indigestion, constipation, hypertension.
Description
본 발명은 비만조절용 건강보조식품 조성물에 관한 것이다. 더욱 상세하게는, 비만 및 과체중의 원인적인 요소 즉, 유전적인 소인, 사회적인 스트레스에 의한 비정상적인 섭생에 대하여 이와 관련된 병의 진행 및 치유과정에 긍정적인 효과를 줄 수 있는 인체에 무해한 건강보조식품 조성물에 관한 것이다.The present invention relates to a dietary supplement for controlling obesity. More specifically, the present invention relates to a health food composition that is harmless to the human body, which may have a positive effect on the progression and healing of diseases related to the cause of obesity and overweight, that is, genetic predisposition and abnormal stress caused by social stress. It is about.
국가의 사회와 경제가 발전함에 따라 음식 문화의 다양화, 칼로리 섭취의 증가, 운동의 부족, 스트레스의 증가로 인한 신체 내의 여러 변화 등과 더불어 유전적인 소인으로 많은 사람들이 비만과 과체중 및 그와 연관된 여러 증상과 질환으로 국민건강에 위협을 받고 있는 실정이다. 비만증은 거북하고 아름답지 않은 외모로 보는 이에게 좋지 않은 이미지를 주고 활동에도 불편을 줄 뿐 아니라, 비만인은 정상인에 비하여 당뇨병, 동맥경화증, 고혈압증, 심장병, 지질장애와 같은 심혈관계 질환의 위험률 및 역류성식도염과 관련된 소화장애, 여성의 월경불순에도 관련될 뿐 아니라 간장병, 담석증, 통풍, 신장병 등의 발생률과 수술시 위험성이 높아 사망률과도 관계가 있음은 과거 많은 연구를 통해 이미 알려져 있다. 따라서 비만증은 중년을 넘어선 사람에게는 생명에 관한 문제이며, 젊은 여성에게는 특히 미용상의 이유로 심각하게 고려되고 있다.As the country's society and economy develop, genetic predisposition, along with diversification of food culture, increased calorie intake, lack of exercise, and increased stress, has led many people to become obese, overweight and associated with Symptoms and diseases are threatened by public health. Obesity not only gives a poor image and uncomfortable appearance to the viewer, but also obesity is associated with risk of cardiovascular diseases such as diabetes, arteriosclerosis, hypertension, heart disease, and lipid disorders compared to normal people. Many studies have been known to be related to digestive disorders related to esophagitis and dysmenorrhea in women, as well as to the incidence of liver disease, cholelithiasis, gout, kidney disease, and high mortality. Therefore, obesity is a life issue for those who are over the middle age, and is considered seriously for young women, especially for cosmetic reasons.
체중 및 부작용의 감소를 위한 방법으로 조깅, 수영, 사이클, 헬스와 같은 운동을 하거나 아니면 절식 또는 약물을 복용하고 있다. 현재까지 운동이 체중의 감소와 유지에 가장 효과적인 것으로 알려져 있으나, 현대생활에 있어 매일 거르지 않고 운동을 하기란 쉽지 않은 일이며 운동 후의 증가된 식욕 또한 억누르기가 쉽지 않아 운동으로 체중조절을 하고 유지한다는 것은 어려운 일이다. 식사조절을 통한 방법의 경우에도 외식의 기회가 많고 인스턴트 식품이 범람하는 현대생활에서 매 식사마다 칼로리를 계산하면서 음식을 복용한다는 것은 소수의 몇 명을 제외하고는 쉽지 않은 일이다. 또한 다른 방법으로서 행동 수정 프로그램을 통해 체중감소를 시도하는 노력도 있는데, 이 방법은 10인 일조로 구성된 집단이 일주일에 1∼2시간씩 12∼20주간 수행되는 것으로 재정적인 부담이 높아 소수의 사람들에게만 혜택이 돌아가며 기간도 길다는 단점이 있다. 마지막으로 기존의 치료방법 중 약물요법이 있다. 상기 약물을 제외한 요법들이 치료에 효과는 있지만 장기간 시행해야 한다는 단점이 있으므로 보다 쉽고 효과적으로 알려진 약물치료에 많은 사람들이 관심을 갖고 있다. 그러나 현재까지는 이러한 약제의 적용범위나 효과 그리고 장기간에 걸친 부작용 등이 정확히 밝혀지지 않은 상태이므로 약물에 의존하기도 불안한 것이 현실이다. 그 결과 실패한 비만 및 과체중조절의 실패를 다른 방법으로 극복해 보려는 여러 시도가 추구되었다. 그 중 하나로서 극단적인 금식이나 인체에 해로운 식물을 무절제하게 복용하는 방법은 정신적인 고통과 더불어 뇌와 연관된 호르몬체계, 간, 신장, 위, 췌장 등 신체에 전체적인 부조화를 초래할 수 있다. 그 결과 인체에 돌이킬 수 없는 치명적인 해를 유발하거나 사망에 이르게 할 수도 있다.As a way to reduce weight and side effects, you can exercise, such as jogging, swimming, cycling, fitness, or fasting or taking medication. To date, exercise is known to be the most effective for weight loss and maintenance, but in modern life it is not easy to exercise without strain every day, and the increased appetite after exercise is not easy to suppress. It is difficult. Even in the way of dietary control, it is not easy for a few people to take food while counting calories at every meal in modern life where there are many opportunities for eating out and overflowing with instant food. Another approach is to try to lose weight through a behavioral modification program, which consists of a group of 10 people, 12 to 20 weeks a week or so, with a small financial burden. The benefit is that only works for a long time. Finally, one of the existing treatments is drug therapy. Therapies other than the above drugs are effective in the treatment, but have a disadvantage in that they need to be administered for a long time, so many people are interested in easier and effective known drug treatments. However, until now, the scope, effect and long-term side effects of such drugs are not known precisely, so it is unstable to rely on drugs. As a result, several attempts have been pursued to overcome the failed obesity and overweight failures in other ways. For example, extreme fasting or the use of plants that are harmful to the human body can lead to mental distress and overall disharmony in the body, including the hormone-associated hormone system, liver, kidneys, stomach, and pancreas. This can cause irreversible fatal harm or even death.
본 발명자들은 상기와 같은 종래의 비만 및 과체중의 조절을 위한 치료방법들의 단점을 해결하기 위하여 오랜 동안 식생활을 통하여 안전성이 입증된 식품들을 적합한 비율로 혼합, 복용시킨 결과 특별한 운동이나 음식의 조절없이 생활속에서 안전하며 짧은 기간 내 남녀노소에 무관하게 원하는 만큼의 체중을 줄이고 생활의 질을 향상시킬 수 있는 건강보조식품을 발명하게 되었다.The present inventors mixed and taken foods that have been proven to be safe through diet for a long time in order to solve the disadvantages of the conventional methods for the control of obesity and overweight, and without any special exercise or food control Invented a dietary supplement that is safe in the stomach and can reduce weight as much as desired and improve the quality of life regardless of age or gender.
따라서 본 발명의 목적은 비만 및 과체중의 조절을 위한 건강보조식품 조성물을 제공함에 있다.Therefore, an object of the present invention is to provide a dietary supplement composition for the control of obesity and overweight.
본 발명의 상기 목적은 비만 및 과체중의 조절을 위해 복잡한 과정 없이 간편하고 효과적인 복용방법을 통해 비만 및 과체중의 조절 이외에도 이와 연관된 많은 성인병 예방과 치유에 효과적이고, 이를 섭취하며 식사량을 줄이더라도 정상적인 사회생활에 지장을 주지 않고 효율적으로 체지방을 감소시킬 수 있으며, 본 발명 건강보조식품의 복용을 중단하더라도 일정 기간 내에는 다시 비만의 상태로 되돌아가지 않는 비만조절용 건강보조식품을 개발하고자, 각종 생약재를 여러 비율로 배합하는 실험을 거듭하고 그 효과를 확인함으로써 본 발명을 달성하였다.The above object of the present invention is effective to prevent and cure a lot of adult diseases related to obesity and overweight through simple and effective dosage method without complicated process for the control of obesity and overweight, and ingest it and reduce the amount of meal normal social life It is possible to reduce body fat efficiently without affecting the obesity, and even to stop taking the health supplements of the present invention to develop obesity control health supplements that do not return to obesity within a certain period of time, various herbal medicines in various ratios This invention was achieved by repeating the experiment to mix | blend and confirming the effect.
이하 본 발명의 구체적인 구성 및 효과를 실시예를 들어 설명하지만 식품종류의 선택 및 조성비의 변경 등은 건강보조식품의 효과를 저하시키고 당업자 간에 권리의 범위를 의도적으로 무의미하게 변경을 꾀할 수 있음은 물론이며 이와 같은 수치 범위의 변경은 본 발명의 권리범위 내 속하는 것은 물론이다.Hereinafter, the specific configuration and effects of the present invention will be described with reference to examples, but the selection of food types and the change in composition ratio may deteriorate the effects of health supplement foods and intentionally and intentionally change the scope of rights among those skilled in the art. Of course, the change in the numerical range falls within the scope of the present invention.
본 발명의 바람직한 실시예에 따르면, 야두(4∼10 중량%), 야홍두 (2∼8중량%), 야흑두(4∼10 중량%), 차전자(0∼5 중량%), 올리브유 0∼5 중량%를 세척하고 건조 후 기름으로 만들고, 기타 자귀나무 2∼8 중량%, 녹두 1∼7 중량%, 소방목 2∼8 중량%, 타마린 4∼10 중량%, 넝쿨콩 4∼10 중량%, 방기 2∼8 중량%, 저령 3∼9 중량%, 야소두 3∼9 중량%, 활석 0∼4 중량%, 동규자 2∼8 중량%, 독활 2∼8 중량%, 감초 1∼7 중량%, 빈랑 2∼8 중량%, 목통 2∼8 중량%, 상기생 2∼8 중량%는 잘게 분쇄하여 분말로 가공한 다음, 혼합함으로써 혼합분말을 가공한다.According to a preferred embodiment of the present invention, yadu (4 to 10% by weight), red beans (2 to 8% by weight), dark bean (4 to 10% by weight), char (0 to 5% by weight), olive oil 0 Wash and dry to 5% by weight to make oil, other 2 ~ 8% by weight of other silk tree, 1 ~ 7% by weight of mung bean, 2 ~ 8% by weight of fire wood, 4-10% by weight of tamarin, 4-10% by weight of vine beans , 2 to 8% by weight, 3 to 9% by weight, 3 to 9% by weight of bean curd, 0 to 4% by weight of talc, 2 to 8% by weight of copper sperm, 2 to 8% by weight of licorice, 1 to 7% by weight of licorice , 2 to 8% by weight, 2 to 8% by weight of the barrel, 2 to 8% by weight of the raw material is finely pulverized into a powder, and then mixed to process the mixed powder.
자귀나무(Albizzia julibrissin Dura)는 중부와 남부의 바다기준높이 500∼700m 되는 산과 들에 자라고 껍질에 알칼로이드, 탄닌질, 사포닌 등이 있으며, 잎에는 쿠에르찌트린, 어린잎에는 비타민 C 200㎎%, 씨에는 알칼로이드가 들어있으며 배당체 알비토찐이 있다. 동의치료에서 진정약, 오줌내기약, 아픔멎이약, 벌레떼기약으로 명치끝이 아프고 잠을 이루지 못할 때, 골절, 종창에 쓰인다.Albizzia julibrissin Dura grows in mountains and fields of 500 ~ 700m height in the central and southern seas, and has alkaloids, tannins, and saponins in its bark. Seeds contain alkaloids and have glycoside albittochin. In motion therapy, sedatives, peeing medicines, pain medicines, insect bugs are used for fractures and swellings when the end of the tooth is sore and unable to sleep.
녹두(Phaseolus radiatus L.)는 높이 20∼50㎝되는 한해살이풀로 씨에는 비타민, 탄수화물 53.6%, 단백질 25.6%, 기름 0.7%가 들어 있다. 비타민으로는 프로비타민A(0.22㎎%), B1(0.53㎎%), B2(0.12㎎%), PP(1.8㎎%)가 있다. 탄수화물로서는 66%의 농마, 5.3%의 펜토잔, 1%의 갈락탄과 이밖에 포도당, 라피노즈, 사탕, 덱스트린 등이 있고 단백질에는 파제올린단백질이 들어 있다. 동의치료에서 씨를 단독, 악창, 술독, 관락 등에 오줌내기약, 지갈약, 열내림약, 독풀이약으로 쓴다.Mung bean (Phaseolus radiatus L.) is an annual herb, 20-50 cm tall, with seeds containing 53.6% vitamins, carbohydrates, 25.6% protein, and 0.7% oil. Vitamins include provitamin A (0.22 mg%), B 1 (0.53 mg%), B 2 (0.12 mg%), and PP (1.8 mg%). Carbohydrates include 66% horses, 5.3% pentozanes, 1% galactan, glucose, raffinose, candy, dextrins, and proteins contain pazeolin proteins. In motion therapy, the seeds are used as urinary medicine, fertilizer, heat lowering medicine, and poisonous medicine alone, in severe intestines, alcohol poisoning, and pipe.
소방목(Caesalpina Sappan L.)은 높이 5m에 이르는 떨기나무로 인도의 동부, 중국의 남부와 동남아시아(인도네시아, 스마트라, 말레이시아)에 퍼져있다. 나무원줄기를 베서 껍질과 목질부 변두리를 깎아버리고 가운데부분(소방목, 나무속살)만을 말린다. 나무속살에는 브라실린 C16H14O5이 2% 들어 있고 이화합물은 연누른색의 결정으로 공기에서 산화되어 붉은색의 브라실레인 C16H12O5으로 된다. 동의치료에서는 나무속살을 피와 경락을 통하게 하며 아픔을 멈춘다고 몸푼 뒤의 병과 타박상 등에 2.5∼4g을 사용하였고, 수렴성피멎이약으로 위카다르, 적리 등에도 쓴다.Firewood (Caesalpina Sappan L.) is a 5 m tall shrub that spreads throughout eastern India, southern China and Southeast Asia (Indonesia, Smartra, Malaysia). Cut off the main stem of the tree and cut the bark and the edges of the wood part and dry only the middle part (pine, wood). The bark contains 2% of brasilin C 16 H 14 O 5, which is a light yellowish crystal that is oxidized in air to give a red brasilin C 16 H 12 O 5 . In motion therapy, 2.5 ~ 4g is used for the disease and bruise after the pain of stopping the pain through blood and meridians.
야흑두는 단백질의 함량이 매우 높으며 탄수화물, 플라보노이드, 스테린, 유기산, 비타민, 이소플라보노이드, 쿠메스탄이 있고, 동의치료에서는 임신, 콩팥염 때 오줌내기약으로 쓰인다.Night bean has a very high protein content and contains carbohydrates, flavonoids, sterins, organic acids, vitamins, isoflavonoids and kumestan. In motion therapy, it is used as a urine medicine during pregnancy and kidney disease.
타마린(Tamarind)은 콩과 장미목 상록교목으로 높이 약 20㎝로 잎은 담녹색의 깃꼴겹잎이며 길이 10∼20㎝의 통모양 누에콩과 비슷한 두과는 성숙되어도 꼬투리가 벌어지지 않는다. 열매는 생식 외에 음료, 조미료, 약용(정장제) 등으로 쓰이며, 어린 식물 잎, 꽃, 어린 꼬투리는 채소로 이용된다.Tamarind is a soybean and rosewood evergreen tree, about 20cm high, leaves are light green quills and 10 ~ 20cm long, similar to tubular silkworm beans. Fruits are used for beverages, seasonings, medicinal (glyphs) in addition to raw food, and young plant leaves, flowers, and young pods are used as vegetables.
당콩 또는 강낭콩이라 불리우는 넝쿨콩(Phaseolus vulgaris L.)은 씨의 단백질함량이 31%로 고기에 가깝고 물고기보다도 높으며 이 단백질을 이루고 있는 아미노산 조성은 고기와 비슷하고 보통방법으로 가공하여도 75%가 흡수된다. 탄수화물, 플라보노이드, 스테린, 유기산, 비타민, 이소플라보노이드, 쿠메스탄이 있으며 특히, 플라보노이드성분인 파세올리신, 파세올린이소플라반, 키에비논의 성분은 일종의 비루스를 억제하는 작용을 한다고 알려져 있다. 씨는 흡수가 잘되는 단백질이 많아 좋은 영양제로 될 뿐만 아니라 생물학실험에 쓰이는 피토게마글루티닌을 만드는데도 쓰인다. 동의치료에서는 임신, 콩팥염 때 오줌내기약으로 쓰인다.Phasseolus vulgaris L., called sugar or kidney beans, has 31% protein content of seeds, close to meat and higher than fish. The amino acid composition of this protein is similar to meat and absorbed 75% even when processed by ordinary methods. do. Carbohydrates, flavonoids, sterins, organic acids, vitamins, isoflavonoids, cumestane, and in particular, flavonoids, parseolisin, parseolin isoflavane, kibininone components are known to act to inhibit the kind of virus. Seed is a good nutrient because it contains a lot of protein that can be absorbed, and it is also used to make phytogemagglutinin for biological experiments. In motion therapy, it is used as a urine medicine during pregnancy and kidney disease.
야두(Rhynchosia volubilis Loureiro)는 민간에서 전초를 허리와 배가 아픈데, 머리아픈데 달여 먹으며 가래약으로도 쓰인다.Yahdu (Rhynchosia volubilis Loureiro) is a civilian outpost that has pain in the lower back and stomach.
방기(Sinomenium acutum Rehder et Wilson)은 남부의 바다기준높이 500m 아래의 산기슭에서 자라는 덩굴뻗이 나무로 뿌리와 줄기에 시노메닌 C19H23O4N, 이소시노메닌, 디시노메닌 C38H44O8N2,t-시낙틴 C20H21O4N, 투두라닌 C18H19O3M, 아쿠투민 C19H24O6NCl, 마그노플로린과 같은 알칼로이드와 β-시토스테롤, 스티그마스테롤이 있다. 동의치료에서 염증약, 오줌내기약, 아픔멎이약으로 물고임, 신경아픔, 관절염, 류마치스, 각기때에 쓰인다.Sinomenium acutum Rehder et Wilson is a vine growing in the foothills of the southern sea level below 500m and is composed of cynomenin C 19 H 23 O 4 N, isosinomenin, and disinomenin C 38 H 44 O 8 N 2 , t -cinactin C 20 H 21 O 4 N, tuduranine C 18 H 19 O 3 M, aquatumin C 19 H 24 O 6 NCl, alkaloids such as magnoflorin and β-sitosterol, stigmasterol There is this. In the treatment of motion, inflammatory drugs, urine medicines, pain medicines, bites, nerve pain, arthritis, rheumatism, respectively.
저령(Grifola umbellata Pilat)은 참나무뿌리혹버섯의 균핵으로 동의치료에서 열내림약, 지갈, 오줌내기약으로 콩팥질병, 물고임, 붓기에 쓰며 오줌길염증에 황백피, 활석과 함께 쓴다. 저령은 솔뿌리혹처럼 물과 습을 내보내고 곪긴 것을 없애며 열을 내리는 약효가 있다.Girola umbellata Pilat is a fungal nucleus of oak roots or mushrooms. It is used as a lowering medicine, jigal and urinary medicine in synonymous treatments, and with kidney disease, bite and swelling. The ghost has the effect of letting out heat and moisture, removing the steamed water, like a pine cone.
야소두는 지방산, 바로미친산, 스테아린산, 알길산, 사포닌, 회분이 풍부하며 동의치료에서 임신, 콩팥염 때 오줌내기약으로 쓰인다.Yasodu is rich in fatty acid, baromicin acid, stearic acid, algilic acid, saponin, and ash. It is used as a urine medicine during pregnancy and kidney disease.
확석의 주요 성분으로는 회분이 있다.Ash is the main component of stone.
동규자(Malca vericillata L.)는 아욱의 씨로 점액이 있고 단백질과 15∼30%의 기름이 있으며, 동의치료에서 오줌내기약, 약한 설사약, 젖내기약으로 물고임과 림질 및 오줌을 누지 못하고 뒤가 굳을 때, 젖이 적을 때 사용한다.Dong Kyuja (Malca vericillata L.) is a mallow seed with mucus, protein and 15-30% oil, and it is hard to squeeze, stiffen, and pee with urine, weak diarrhea, and lactation in motion therapy. Use when milk is low.
야홍두는 단백질의 함량이 매우 높으며 탄수화물, 플라보노이드, 스테린, 유기산, 비타민, 이소플라보노이드, 쿠메스탄이 있고, 동의치료에서는 임신, 콩팥염 때 오줌내기약으로 쓰인다.Sprouts are very high in protein and contain carbohydrates, flavonoids, sterins, organic acids, vitamins, isoflavonoids and kumestan. In motion therapy, they are used as urinary drugs during pregnancy and kidney disease.
독활(Aralia continentalis Kitagawa)은 땃두릅의 뿌리 및 뿌리줄기로 정유, 스테아린산, 수지, 살리찐산과 미량원소로 동, 망간, 니켈 등이 들어 있으며 피마르산과 비슷한 구조를 가지는 디테르펜계화합물인 디테르펜산 Ⅰ과 Ⅱ가 들어 있으며, 심장운동을 강화하고 심장수축의 진폭을 크게 하며 숨쉬기, 장윤동운동을 항진시키고, 동의치료에서는 땀내기, 구풍, 아픔멎이약으로 관절염, 감기, 붓기, 머리아픔, 이아픔, 신경아픔, 류마치스, 피부가렴증에 쓰인다.Aralia continentalis Kitagawa is a diterpenic acid, diterpene-based compound having similar structure to pymaric acid, containing essential oils, stearic acid, resin, salinic acid and trace elements such as copper, manganese and nickel It contains Ⅰ and Ⅱ, strengthens the cardiac movement, increases the amplitude of the heart contraction, promotes breathing, intestinal lubrication movement, and in the motion therapy, sweating, gust, pain and pain medicine, arthritis, cold, swelling, head pain, It is used for tooth pain, nerve pain, rheumatism, and dermatitis.
차전자(Plantago asiatica L.)는 질경이의 씨로 아우쿠빈과 많은 점액이 있으며 플란테놀산, 호박산, 콜린, 아데닌, 비타민 A, B1이 있다. 동의치료에서는 습열을 없애고 눈을 밝게 한다고 하여 눈병, 방광염, 장카타르, 피오줌, 설사, 적리때 염증약, 오줌내기약, 설사멎이약으로 쓰였고, 기침가래약으로 백날기침, 기관지염 등의 호흡기질병에도 사용하였다.Plantago (Plantago asiatica L.) is a seed of plantain that contains aquabines and many mucus, as well as plantenolic acid, succinic acid, choline, adenine, vitamins A and B1. In motion therapy, it was used for eye disease, cystitis, jang catarrh, blood pee, diarrhea, and inflammatory medicine, urinary medicine, diarrhea, and diarrhea. Also used.
감초(Glycyrrhiza glabra L.)는 뿌리와 뿌리줄기에 글리찌리진이 5∼14%(많은 것은 23%), 글라브라산(글리찌레틴, C30H46O5)이 있다. 감초뿌리의 유효성분으로 알려져 있는 글리찌리진은 사탕의 약 40∼50배정도로 단맛이 있으며, 글리찌리진의 물분해에 의하여 생긴 글리찌레틴산은 단맛이 없고 용혈작용이 있다. 글리찌리진은 또한 호흡기도를 완화시킨다. 감초뿌리는 가래삭임작용, 완화작용, 항염증작용과 진경작용, 항히스타민작용 등이 있고, 약품의 맛고침약, 독풀이약, 부형약으로 쓰이며, 요즘에는 위십이지장궤양, 아디손병, 기관지천식, 황달과 간염, 습진을 비롯한 피부병 등에 널리 쓰이고 있다.Licorice (Glycyrrhiza glabra L.) contains 5-14% of glytirizine (23% in many cases) and glabraic acid (glycitretin, C 30 H 46 O 5 ) in the roots and rhizomes. Glycirizine, known as an active ingredient of licorice root, has a sweet taste of about 40 to 50 times that of candy, and glycyrrhetinic acid produced by the hydrolysis of glycirizine has no sweetness and has a hemolytic action. Glyzirizine also relieves the respiratory tract. Licorice root has sputum sputum action, alleviation effect, anti-inflammatory effect and antifungal action, antihistamine action, and it is used as a medicine taste intoxicant, poison pill, and excipient. It is widely used in hepatitis, eczema and other skin diseases.
빈랑(Areca Catechu L.)은 씨에 0.4%의 알칼로이드가 있는데, 이의 주성분은 아레콜린 C8H13NO2이 들어 있으며, 이밖에 아레카이딘 C7H11NO2, 구바콜린 C7H11NO2, 구바찐 C6H9NO2이 있다. 또한 씨에는 14∼18%의 기름이 들어 있으며 기름의 50%는 라우린, 21%는 미리스틴, 29%는 올레인이고 팔미틴, 스테아린, 카프린도 있다. 아레콜린은 필로카르핀, 에제린처럼 부교감신경의 기능을 항진시키는 작용이 있어 동공을 축소시키고 분비선의 분비를 항진시킨다. 그러므로 빈랑자를 씹을 때에는 땀, 침, 소화액 등의 분비가 촉진한다.Betel nut (Areca Catechu L.) contains 0.4% alkaloids in seeds, the main component of which contains arecholine C 8 H 13 NO 2 , in addition to arecaidine C 7 H 11 NO 2 , guavacholine C 7 H 11 NO 2 , gubachin C 6 H 9 NO 2 . Seeds also contain 14-18% oil, 50% oil is laurin, 21% myristin, 29% oleine, palmitine, stearin and caprine. Arecoline, like pilocarpine and ezerine, has the function of hypersympathetic nerves to reduce the pupils and secrete glands. Therefore, when chewing betel nut, the secretion of sweat, saliva, digestive juices, etc. are promoted.
목통(Akebia Quinata Decaisne)은 으름덩굴의 줄기로 헤데라게닌과 올레아놀산을 비당부분으로 한 여러가지 트리테르펜사포닌이 있고, 줄기 달임약과 링크는 급성 및 만성 동물실험에서 뚜렷한 오줌내기와 강심작용이 있음이 확인되었다. 동의치료에서는 염증약, 오줌내기약, 아픔멎이약, 배농약으로 콩팥염, 심장병으로 인한 붓기, 신경통, 관절염, 임신부의 붓기 때에 쓰고, 다른 약과 섞어서 통경약으로 월경불순, 월경아픔 때도 사용한다.The neck (Akebia Quinata Decaisne) is a stalk of vines and has various triterpensaponins with non-sugars of hederagen and oleanolic acid.The stem decoction and the link have distinct urinary and cardiovascular effects in acute and chronic animal experiments It became. In motion therapy, inflammatory drugs, urine medicine, pain medicine, pear pesticides are used for kidney disease, swelling caused by heart disease, neuralgia, arthritis, and swelling of pregnant women, and mixed with other medicines for dysmenorrhea and menstrual pain.
상기생(Loranthus Tanakae Franchet et Savatt)은 꼬리겨우살이의 전초로 중국산 상기생의 잎이 붙은 줄기에는 아비쿨라린 C20H18O11이 있다. 상기생은 콜레스테롤성 경화피줄을 뚜렷하게 확장하여 동의치료에서는 풍습으로 인한 아픔, 허리아픔에 땃두릅뿌리, 방풍뿌리, 속단뿌리, 태용돌안에 당귀뿌리, 차즈기줄기, 협심증과 고혈압에 두충, 칡뿌리, 속썩은풀뿌리, 꿀풀, 잇꽃과 같이 사용하며 이밖에도 산후병, 붕류, 하혈과 젖이 없을 때에 사용한다.Loranthhus Tanakae Franchet et Savatt is an outpost of tail mistletoe and has abiculin C 20 H 18 O 11 in the stems attached to the leaves of Chinese native lanceolates. In the above treatment, the cholesterol-rich hardened skin is clearly expanded, and in motion therapy, the pain caused by the custom, the pain in the lower back, the wind root, the inner root, the donkey root in the Taeyongdol, the tea stem, the angina and high blood pressure It is used together with silver roots, nectar and safflower. It is also used in the absence of postpartum disease, stalks, bleeding and milk.
올리브유(Olea eurapaea L.)는 감람나무로도 불리우고 열매살에 50∼70%, 씨에 20%의 기름이 있는데 기름의 7∼10%는 팔미틴, 2∼4%는 스테아린, 70∼84%는 올레인, 4∼12%는 리놀레인이다. 올리브유는 먹거나 캄파, 성호르몬 등과 같은 의약품의 주사용 용매로 사용된다.Olive oil (Olea eurapaea L.), also called olive tree, has 50-70% oil in the flesh and 20% oil in the seeds, with 7-10% of palmitine, 2-4% of stearin, and 70-84% of oil. Olein, 4-12% is linoleine. Olive oil is used as a solvent for injection or injection of medicines such as camphor and sex hormones.
본 발명은 식품으로 인체에 전혀 해롭지 않고 우리가 항상 먹고 있는 식품원료 중에서 들에서 자생하고 있는 가식성(edible) 식품원료인 자귀나무, 녹두, 소방목, 타마린, 야흑두, 덩굴콩, 야두, 방기, 저령, 야소두, 홀석, 동규자, 야홍두, 독활, 차전자, 감초, 방기, 상기생, 목통을 미세하게 분쇄한 후, 건조하여 혼합분말가루로 만든 것으로, 인체에 해롭운 것이 없고 그 성분 중에는 이뇨와 해독작용 또는 체중감소 등의 신진대사 작용에 관여하는 것이 있으므로 유용한 것이다.The present invention is a food that is not harmful to the human body at all and is always a edible food raw material that grows in the field among the food raw materials we eat all the time, algae, green beans, fire wood, tamarin, black bean, vine beans, yadu, Banggi, Finely pulverized oyster, yasodu, whole stone, Donggyuja, hongdudu, poison, tea, licorice, anti-air, hygiene, and wood, and then dried and mixed with powder powder. And it is useful because it is involved in metabolic actions such as detoxification or weight loss.
본 발명에 사용된 식품원료들의 각각 성분을 보면 야소두와 야홍두의 회분,샤포닌, 스테아린산, 아라키딕산, 팔미틱산 성분, 동규자의 지방유, 단백질성분, 저령의 에르고스테롤, 비오틴의 성분, 자귀나무의 알비진과 비타민 C 성분, 녹두와 덩굴콩의 전분, 소방목의 브라질린성분, 타마린의 유산과 타르탈산 성분, 야흑두의 리놀레인과 올레인 성분, 야두 및 야흑두의 인, 리보플라빈, 티아민 성분, 활석의 함수규산마그네슘 성분, 독활의 정유 및 피토스테롤 성분, 차전자의 아스랄린, 감초의 리콜라이스 성분 등이 유효하다.The components of the food ingredients used in the present invention are the ash content of Yasodu and Yahongdu, chaponin, stearic acid, arachidic acid, palmitic acid, fatty oil of copper ruler, protein component, aging ergosterol, biotin component, silk tree Alzine and vitamin C, starch of mung beans and vine beans, braziline of firewood, lactic acid and tartalic acid of tamarin, linolein and olein of black bean head, phosphorus, riboflavin, thiamine, Magnesium hydrous silicate component of talc, essential oil and phytosterol component of poisonous activity, arslan of charcoal, licorice component of licorice, etc. are effective.
본 발명 비만조절용 건강보조식품원료 분말의 상호 혼합비율은 남녀노소에 큰 변수가 되지 못하므로 복용 권고대상은 초등학교 이상의 연령 군에서 체질량지수(BMI = ㎏/m2)가 과체중 지표인 25 이상을 나타내는 남녀노소이다. 그러나 체질량 지수가 과체중 및 비만의 범주에 포함되지 않더라도 본인이 비만으로 생활에 불편함을 느끼고 있는 모든 사람은 복용 가능하다.Since the intermixing ratio of the health supplement food ingredient powder for controlling obesity of the present invention does not become a big variable for men and women and young children, the recommended subjects have a body mass index (BMI = kg / m 2 ) of over 25, which is an overweight index in the age group of elementary school or older. All ages. However, even if the body mass index is not included in the categories of overweight and obesity, it can be taken by anyone who feels uncomfortable due to obesity.
본 발명의 건강보조식품 조성물에 함유되는 성분은 모두 생약재, 식품재료 및 식품으로 사용되는 것으로, 복용 또는 섭취시 인체에 대한 안전성이 우수하다.Ingredients contained in the dietary supplement composition of the present invention are all used as a herbal medicine, food ingredients and food, it is excellent in safety for the human body when taking or ingesting.
본 발명에 따른 바람직한 식품 조성물의 제형은 통상의 방법에 따라 분말화한 것이지만, 열수 또는 유기용매로 추출하여 담체를 넣어 건조한 후 캡슐화 하거나 기타 정제, 과립, 분말, 음료, 죽 등의 형태로 제형화할 수 있다.The formulation of the preferred food composition according to the present invention is powdered according to a conventional method, but is extracted with hot water or an organic solvent, dried with a carrier, then encapsulated, or formulated in the form of other tablets, granules, powders, beverages, porridge, and the like. Can be.
본 발명 비만조절용 건강보조식품은 60㎏ 이상, 60세 미만인 성인남녀가 15g 정도 되는 정제 또는 캡슐 형태의 혼합분말을 한번에 2알씩(30g) 하루 세 번, 공복에 1 개월간 복용하는 것이 바람직하다. 본 발명 비만조절용 건강보조식품은 소아및 노인도 복용가능하며 용량은 성인의 ½인 한 알(15g)을 상기와 동일한 방법으로 복용한다.In the present invention, the obesity control health supplement food is more than 60kg, adult male and female less than 60 years old 15g tablets or capsules in the form of a mixed powder 2 capsules at a time (30g) three times a day, preferably on an empty stomach for 1 month. The obesity control health supplement food of the present invention can be taken by children and the elderly, and the dose is ½ of an adult (15g) is taken in the same manner as above.
본 발명 비만조절용 건강보조식품의 비만조절 효능은 상기 식품원료의 적절한 배합비율로 구성된 식품 조성물을 경구투여방법으로 복용함으로써 체내 지방분을 에너지로 변환시키고 또한, 체내 수분에 대해서는 이뇨작용을 촉진하여 신진대사를 활성화시키는 것으로 판단된다. 따라서, 긴 시간을 비만 조절에 투자해야 되는 기존의 여타 방법과는 달리 비용과 시간을 절감하면서 이상의 효과를 얻을 수 있는 잇점이 있다.Obesity control effect of the present obesity control health supplement foods by converting the body fat content into energy by taking oral administration of a food composition consisting of the appropriate blending ratio of the food ingredients, and promotes the diuretic effect on the body water metabolism metabolism It is determined to activate. Therefore, unlike other methods that require a long time to control obesity, there is an advantage that can be achieved while reducing the cost and time.
본 발명 비만조절용 건강보조식품 조성물의 바람직한 실시예를 들면 다음과 같다.For example, a preferred embodiment of the present obesity control health supplement composition is as follows.
실시예 1. 비만조절용 조성물(단위 : 전체 100에 대한 중량%)Example 1 Composition for Controlling Obesity (Unit: Weight% to Total 100)
자귀나무 5 중량%Silk tree 5% by weight
녹두 4 중량%Mung Bean 4 wt%
소방목 5 중량%5% by weight of fire wood
타마린 7 중량%Tamarin 7 wt%
야흑두 7 중량%Dark bean 7 wt%
넝쿨콩 7중량%7% by weight of vine beans
야두 7 중량%Yadu 7 wt%
방기 5 중량%5% by weight
저령 6 중량%Age 6 wt%
야소두 6 중량%Yasodu 6 wt%
활석 1 중량%Talc 1% by weight
동규자 5 중량%Copper weight 5 wt%
야홍두 6 중량%Yahongdu 6 wt%
독활 5 중량%5% by weight of poison
차전자 2 중량%2% by weight of car
감초 4 중량%Licorice 4 wt%
빈랑 5 중량%Betel 5% by weight
목통 5 중량%5% by weight of neck
상기생 6 중량%6 wt%
올리브유 2 중량%2% by weight of olive oil
이하, 본 발명의 실시예에 따른 비만증 억제 효과를 측정하기 위한 동물실험 및 인체에 적용한 임상학적 실험과 그 결과를 제시한다.Hereinafter, animal experiments for measuring the effect of inhibiting obesity according to an embodiment of the present invention and clinical experiments applied to the human body and the results are presented.
실험예 1 : 비만증 억제효과 실험(동물실험)Experimental Example 1: Obesity Inhibitory Effect Experiment (Animal Experiment)
⑴ 동물실험⑴ Animal experiment
본 실험에 사용된 공시동물은 3주령의 스프래그-다울리(Sprague-Dawley)계 숫쥐 30마리를 구입하여 1주간 시판 펠렛(pellet) 사료를 급여한 뒤 10마리씩 3군(三群)으로 나누었다. 정상 대조군은 계속 펠렛 사료만 주고 나머지 2개 군은 펠렛 사료와 함께 사람의 비만유형과 가장 유사한 비만증을 유발한다고 알려진 카페테리아 다이어트(cafeteria diet)를 급여하였으며[Nutr. Biochem. 6, 151 (1995)], 모든 사료와 물을 자유급식하였다. 카페테리아 다이어트를 2주간 급여한 후, 카페테리아 다이어트를 급여한 2군 중 한군에게 상기 실시예 1에서 제조한 비만용 건강보조식품 조성물을 0.4 mL가 되게 증류수와 혼합하여 하루 2회 각각 경구투여하였으며, 다른 1군(비만 대조군)에 대하여는 같은 부피(0.4 mL)의 생리식염수를 경구투여하였다. 카페테리아 다이어트로는 쿠키, 비스켓, 쵸콜렛, 땅콩, 치즈, 감자칩, 아몬드, 소세지 및 햄을 급여하였고, 투여량은 사람의 1일 사용량과 사람과 쥐의 체중비율로부터 환산하였다. 시료를 6주간 경구투여한 후, 심장에서 혈액을 채취하고 간, 신장 지방조직(pe rarenal fat pad) 및 정소상체 지방조직(epididiymal fat pad)을 잘라내어 무게를 측정하였다.The test animals used in this experiment were purchased from 30 Sprague-Dawley male rats of 3 weeks old and fed with pellet food for 1 week, and then divided into 3 groups of 10 animals. . The normal control group continued to feed only pellets and the other two groups fed the pellets with a cafeteria diet known to cause obesity most similar to the type of obesity in humans [Nutr. Biochem. 6, 151 (1995)], all feed and water were freely fed. After two weeks of cafeteria diet, one group of two groups fed the cafeteria diet was administered orally twice a day by mixing the dietary supplement composition for obesity prepared in Example 1 with distilled water to 0.4 mL each, For group 1 (obesity control), the same volume (0.4 mL) of saline was orally administered. In the cafeteria diet, cookies, biscuits, chocolate, peanuts, cheese, potato chips, almonds, sausages and ham were fed, and the dosage was converted from the daily consumption of human and the weight ratio of human and rat. After oral administration of the sample for 6 weeks, blood was collected from the heart, and liver, kidney rare tissue (pe rarenal fat pad) and epididymal fat pad (epididiymal fat pad) were cut and weighed.
⑵ 화학분석⑵ Chemical analysis
간의 중성지질을 분석하기 위하여 간의 지질을 추출한 뒤 효소법으로 중성지질을 정량하였다. 혈청의 총 콜레스테롤, HDL-콜레스테롤 및 포도당 함량은 드라이 케미스트리 시스템(dry chemistry system, 일본 Daiichi사 제품)을 이용하여 분석하였다.To analyze hepatic triglycerides, hepatic lipids were extracted and neutral lipids were quantified by enzyme method. Serum total cholesterol, HDL-cholesterol and glucose content were analyzed using a dry chemistry system (manufactured by Daiichi, Japan).
⑶ 실험결과⑶ Experimental results
본 발명 비만조절용 건강보조식품의 비만증 억제기능 조사 결과는 하기 표 1에 나타낸 바와 같다. 비만 대조군에 비하여, 본 발명 건강보조식품은 통계적으로 체중 증가량을 7% 감소시켰으며 열량섭취는 1.4% 감소시켰다. 또한 복부지방의 축적을 억제하였으며, 간의 중성지방 축적을 억제하였다. 이상의 결과를 통하여 본 발명 건강보조식품 조성물이 체중 증가를 억제하여 비만증을 억제 할 수 있을 뿐 아니라, 열량섭취, 복부지방 축적 및 동맥경화 위험지수를 감소시킬 수 있음을 확인하였다.Obesity inhibition function investigation results of the present obesity control health supplements are shown in Table 1 below. Compared to the obese control group, the dietary supplement of the present invention reduced the weight gain by 7% and calorie intake by 1.4%. It also inhibited the accumulation of abdominal fat and the hepatic triglyceride accumulation. Through the above results it was confirmed that the dietary supplement composition of the present invention can not only suppress weight gain and obesity, but also reduce calorie intake, abdominal fat accumulation and arteriosclerosis risk index.
실험예 2 : 비만증 억제효과 실험(인체임상실험)Experimental Example 2: Obesity Inhibitory Effect Experiment (Human Clinical Experiment)
상기 BMI(Body Mass Index)에 의하여 계산된 비만도 25% 이상의 성인 남녀 각 5인에게 아침과 점심 식사 전에 실시예 1에서 제조된 건강보조식품 조성물을 각 8 g 씩 섭취시키고, 저녁 식사로 50 g을 섭취시켰다. 이렇게 4주간 섭취시킨 후 체형, 임상 및 생화학적 측정을 하여 섭취 전과 비교한 결과 표 2에 나타낸 바와 같이, 체중이 평균 9.0 ㎏ 감소하고 체지방 함량이 19.9% 감소하였다. 또한 허리둘레, 상박둘레 및 혈청 총 콜레스테롤과 LDL-콜레스테롤 농도가 섭취 전에 비하여 통계적으로 유의하게 감소하였으며, 섭취 중단 후 한달 간 체중 증가량은 평균 0.86 ㎏에 불과하였다. 이러한 결과는 본 발명의 비만조절용 건강보조식품 조성물이 사람의 비만증을 매우 효과적으로 억제할 수 있으며, 섭취를 중단한 경우에도 빠르게 체중이 증가하는 요요현상이 나타나지 않음을 입증한 것이다.The obesity degree calculated by the Body Mass Index (BMI) to each of five adult men and women at least 8 g each of the health supplement composition prepared in Example 1 before breakfast and lunch, 50 g for dinner Intake. After 4 weeks of ingestion, body weight, clinical and biochemical measurements were compared with those of before consumption, and as shown in Table 2, the average body weight was reduced by 9.0 kg and the body fat content was reduced by 19.9%. In addition, waist circumference, upper arm circumference and serum total cholesterol and LDL-cholesterol concentrations were statistically significantly lower than before ingestion, and the mean weight gain during the month after ingestion was only 0.86 kg. These results prove that the obesity control dietary supplement composition of the present invention can effectively inhibit obesity in humans, and even when the intake is stopped, yoyo phenomenon of rapid weight gain does not appear.
하기에는 상기 실시예 1의 조성물을 사용하여 비만 및 과체중 치료 효과를 보인 것이다.The following shows the effect of treating obesity and overweight using the composition of Example 1.
사용예 1 : 비만증 및 역류성식도염의 치료Use Example 1 Treatment of Obesity and Reflux Esophagitis
상기 실시예 1에 개시(開示)한 비만조절용 건강보조식품 조성물을 조상래(남자), 주소 : 경기도 고양시 덕양구 오금동 33-2호, 주민등록번호 : 370510-1109110, 신장 167㎝, 체중 70㎏, 체질량지수(BMI) 25.1인 환자에게 1988년 4월 5일부터 동년 5월 5일까지 일개월간 본 발명 비만조절용 건강보조식품을 일회 30g 씩 1일 3회 복용한 결과, 신장 167㎝, 체중 63㎏, 체질량지수 22.6으로 결과기간 내 5㎏의 체중감소가 있었고, 복용을 중지한 이후 2개월이 지속되는 기간 동안 2㎏의 추가 체중감소가 있었다. 복용기간과 복용 후에도 정상적인 식사를 병행하였으며 특별한 운동은 시행하지 않았으나, 이후 16∼24개월 동안 기복없이 감소된 체중이 유지되었다. 현재 체질량 지수 22.6으로 자신감을 갖고 생활하고 있다.Obesity control health supplement food composition disclosed in Example 1 (man), address: 33-2 Ogeum-dong, Deokyang-gu, Goyang-si, Gyeonggi-do, Resident Registration Number: 370510-1109110, height 167cm, weight 70kg, body mass index ( BMI) A patient of 25.1 who took the present obesity control health supplement food three times a day three times a day from April 5, 1988 to May 5, the same year, height 167 cm, weight 63 kg, body mass index At 22.6, there was a weight loss of 5 kg in the outcome period, and an additional weight loss of 2 kg for the duration of 2 months after the withdrawal. During and after dosing, normal meals were combined and no special exercise was performed, but weight loss was maintained without relief for 16 to 24 months. I currently live with confidence at a body mass index of 22.6.
사용예 2 : 비만증의 치료Use Example 2: Treatment of Obesity
상기 실시예 1에 개시(開示)한 비만조절용 건강보조식품 조성물을 체질량지수(BMI)가 과체중을 나타내는 지표인 25에 약간 못 미치지만 비만한 느낌으로 생활 중에 불편을 느끼던 손두옥(남자), 주소 : 서울시 강서구 방화동 256번지, 주민등록번호 : 350610-1009226, 신장 169㎝, 체중 70㎏, 체질량지수 24.5인 환자에게 1999년 3월 10일부터 동년 4월 11일까지 상기 사용예 1과 동일하게 일개월간 본 발명 비만조절용 건강보조식품을 일회 30g 씩 1일 3회 복용한 결과, 신장 166㎝, 체중 61㎏, 체질량지수 21.3으로 기간 내 4㎏의 체중감소가 있었고, 복용을 중지한 이후 3개월이 지속되는 기간 동안 3㎏의 추가 체중감소가 있었다. 복용기간과 복용 후에도 정상적인 식사를 병행하였으며 특별한 운동은 시행하지 않았으나, 이후 16∼24개월 동안 기복없이 감소된 체중이 유지되었다. 현재 체질량지수 22.1로 복용 후 체중감소로 자신감을 갖고 생활하고 있다.Sonduok (man) who feels uncomfortable in life with a feeling of obesity, but slightly less than 25 body mass index (BMI) is an indicator of overweight, as shown in Example 1 256, Banghwa-dong, Gangseo-gu, Seoul, Korea Resident Registration No.: 350610-1009226, Height 169㎝, Weight 70㎏, Body mass index 24.5 Patients with a mass mass index from March 10, 1999 to April 11, 1999 As a result of taking 30g of dietary supplements for controlling obesity 3 times a day, there was a weight loss of 4kg within the period of 166cm in height, 61kg in weight, and a body mass index of 21.3. There was an additional weight loss of 3 kg. During and after dosing, normal meals were combined and no special exercise was performed, but weight loss was maintained without relief for 16 to 24 months. Currently taking body mass index of 22.1, he is living with confidence in weight loss.
사용예 3 : 비만증 및 소화불량 치료Use Example 3: Treatment of Obesity and Indigestion
상기 실시예 1에 개시(開示)한 비만조절용 건강보조식품 조성물을 비만증 및 소화불량으로 생활 중 불편함을 호소하던 김정자(여자), 주소 :미국 뉴욕 맨하탄 32가 10001번지, 주민등록번호 : 410406-2000000, 신장 160㎝, 체중 67㎏, 체질량지수(BMI) 26.1인 환자에게 1999년 9월 8일부터 동년 10월 7일까지 상기 사용예들과 동일하게 일개월간 본 발명 비만조절용 건강보조식품을 일회 30g 씩 1일 3회 복용한 결과, 신장 160㎝, 체중 58㎏, 체질량지수 22.6으로 기간 내 6㎏의 체중감소가 있었고, 복용을 중지한 이후 3개월이 지속되는 기간 동안 3㎏의 추가 체중감소가 있었다. 복용기간과 복용 후에도 정상적인 식사를 병행하였으며 특별한 운동은 시행하지 않았으나, 이후 9개월이 지난 지금까지도 기복없이 감소된 체중의 유지하고 있으며 소화불량도 호전되었다.Kim Jung-ja (woman), who complained of discomfort in life due to obesity and indigestion, the obesity control health supplement composition disclosed in Example 1, Address: 10001, Manhattan 32-ga, New York, resident registration number: 410406-2000000, Patients with a height of 160 cm, weight 67 kg, and body mass index (BMI) of 26.1, 30 g each of the present obesity-controlled dietary supplement for once a month from September 8, 1999 to October 7, same year, As a result of taking 3 times a day, there was a weight loss of 6 kg in the period with height 160cm, weight 58kg, body mass index of 22.6, and additional weight loss of 3kg for 3 months after stopping the dose . During the period of administration and after taking normal meals, no special exercise was performed, but nine months later, the weight was maintained without relief, and the indigestion was improved.
사용예 4 : 비만증, 변비 및 고혈압의 치료Use Example 4 Treatment of Obesity, Constipation and Hypertension
상기 실시예 1에 개시(開示)한 비만조절용 건강보조식품 조성물을 출산 후 10년간 본래 체중인 52㎏으로 회복되지 않는 비만증과 변비, 이후 생긴 고혈압으로 약물 복용을 해오던 조은정(여자), 주소 : 서울시 은평구 응암 3동 337-74-24-1, 주민등록번호 : 631012-2482226, 신장 158㎝, 체중 65㎏, 체징량지수(BMI) 26.3인 환자에게 2000년 3월 7일부터 동년 4월 7일까지 상기 사용예들과 동일하게 일개월간 본 발명 비만조절용 건강보조식품을 일회 30g 씩 1일 3회 복용한 결과, 신장 158㎝, 체중 54㎏, 체질량지수 21.6으로 기간 내 6㎏의 체중감소가 있었고, 복용을 중지한 이후 2개월이 지속되는 기간 동안 3㎏의 추가 체중감소가 있었다. 복용기간과 복용 후에도 정상적인 식사를 병행하였으며 특별한 운동은 시행하지 않았다. 환자는 체질량 지수 21.6인 현재 체중감소와 변비의 호전으로 생활에 자신감을 얻었으며, 혈압조절을 위한 약물복용은 하지 않고 있다.Cho Eun-jung (woman), who has been taking medications for obesity and constipation, and high blood pressure, which does not recover to the original weight of 52 kg for 10 years after giving birth to the obesity control health supplement composition disclosed in Example 1, address: Patients with 337-74-24-1, Ngam 3-dong, Eunpyeong-gu, Seoul, Korea Resident Registration Number: 631012-2482226, Height 158㎝, Weight 65㎏, BMI 26.3 From March 7, 2000 to April 7, the same year In the same manner as in the above examples, when the present invention was administered once a day 30g of obesity control health supplements three times a day, there was a weight loss of 6kg in a period of 158cm, weight 54kg, body mass index 21.6, There was an additional weight loss of 3 kg over the course of two months after discontinuation. During and after the dose, normal meals were combined and no special exercise was performed. The patient gained confidence in her life due to her current weight loss and improved constipation, which has a body mass index of 21.6, and is not taking medication for blood pressure control.
이상의 실시예와 실험예 및 사용예에서 설명한 바와 같이 본 발명에 따르면 상기의 비만조절용 건강보조식품을 제공하고, 사용한 경우 부작용 없이 사용자에게 만족감을 주는 뛰어난 효과가 있으며 비만과 과체중의 조절 이외에도 그와 밀접한 연관성을 갖고 있는 역류성식도염, 소화불량, 변비, 고혈압의 치료에 뛰어난 효과가 있으므로 건강의학상 매우 유용한 발명인 것이다.According to the present invention as described in the above Examples, Experimental Examples, and Use Examples, the present invention provides the above-described dietary supplement for obesity control, and when used, has an excellent effect of satisfying the user without side effects, and in addition to controlling obesity and overweight, It is a very useful invention in health medicine because it has an excellent effect in the treatment of reflux esophagitis, indigestion, constipation, and high blood pressure that is associated with.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0038820A KR100419185B1 (en) | 2000-07-07 | 2000-07-07 | Healty food composition for obesity control |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0038820A KR100419185B1 (en) | 2000-07-07 | 2000-07-07 | Healty food composition for obesity control |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020004686A KR20020004686A (en) | 2002-01-16 |
KR100419185B1 true KR100419185B1 (en) | 2004-02-14 |
Family
ID=19676765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0038820A KR100419185B1 (en) | 2000-07-07 | 2000-07-07 | Healty food composition for obesity control |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100419185B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100679290B1 (en) | 2005-06-30 | 2007-02-05 | 박정휘 | A composition comprising an extract of ?????201 crude drug complex as an effective ingredient treating or preventing obesity |
KR100736594B1 (en) | 2005-09-30 | 2007-07-06 | 강세만 | Composition of health food for curing constipation and improving belly fatness and method producing thereof |
KR101325515B1 (en) | 2010-06-15 | 2013-11-07 | 주식회사 미슬바이오텍 | Korean mistletoe extracts having antiobesity and hepatic steatosis protection activity |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100380867B1 (en) * | 2000-12-06 | 2003-04-18 | 한국 한의학 연구원 | Extract of Albizziae Cortex for the prevention and treatment of osteoporosis |
KR100473531B1 (en) * | 2002-01-04 | 2005-03-09 | 씨제이 주식회사 | Composition containing an extract of truncated sopungsungi-won crude drug complex for preventing and treating diabetes |
KR100473530B1 (en) * | 2002-01-04 | 2005-03-09 | 씨제이 주식회사 | Composition containing an extract of sopungsungi-won crude drug complex for preventing and treating diabetes mellitus |
CN102716253B (en) * | 2012-06-18 | 2014-03-05 | 蔡云娥 | Traditional Chinese medicine composition for treating constipation |
KR102197417B1 (en) * | 2019-01-31 | 2021-01-04 | 대구한의대학교산학협력단 | A composition comprising arecae semen extract for preventing or treating Chronic Acid Reflux Esophagitis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970073378A (en) * | 1996-05-08 | 1997-12-10 | 서순덕 | Production method of soymilk containing herbal extracts |
KR19980072976A (en) * | 1997-03-10 | 1998-11-05 | 김병우 | Manufacturing method of health drink based on herbal medicine |
KR19980076168A (en) * | 1997-04-07 | 1998-11-16 | 권영혁 | Hepatoprotective health food based on reed and licorice |
KR20010017482A (en) * | 1999-08-11 | 2001-03-05 | 신상국 | A bervage composition for diet and a mothod manufacting therof. |
-
2000
- 2000-07-07 KR KR10-2000-0038820A patent/KR100419185B1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970073378A (en) * | 1996-05-08 | 1997-12-10 | 서순덕 | Production method of soymilk containing herbal extracts |
KR19980072976A (en) * | 1997-03-10 | 1998-11-05 | 김병우 | Manufacturing method of health drink based on herbal medicine |
KR19980076168A (en) * | 1997-04-07 | 1998-11-16 | 권영혁 | Hepatoprotective health food based on reed and licorice |
KR20010017482A (en) * | 1999-08-11 | 2001-03-05 | 신상국 | A bervage composition for diet and a mothod manufacting therof. |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100679290B1 (en) | 2005-06-30 | 2007-02-05 | 박정휘 | A composition comprising an extract of ?????201 crude drug complex as an effective ingredient treating or preventing obesity |
KR100736594B1 (en) | 2005-09-30 | 2007-07-06 | 강세만 | Composition of health food for curing constipation and improving belly fatness and method producing thereof |
KR101325515B1 (en) | 2010-06-15 | 2013-11-07 | 주식회사 미슬바이오텍 | Korean mistletoe extracts having antiobesity and hepatic steatosis protection activity |
Also Published As
Publication number | Publication date |
---|---|
KR20020004686A (en) | 2002-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kumar et al. | Traditional medicinal uses and therapeutic benefits of Momordica charantia Linn | |
Alhassan et al. | Effects of aqueous avocado pear (Persea americana) seed extract on alloxan induced diabetes rats | |
Jain et al. | A comprehensive review on the nutritional and nutraceutical aspects of garden cress (Lepidium sativum Linn.) | |
US6416795B1 (en) | Herbal extract composition for stress prevention and treatment | |
Navarra | The encyclopedia of vitamins, minerals, and supplements | |
CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
KR102107387B1 (en) | Beverage composition for treating hangover comprising black ginseng extact | |
KR20170060307A (en) | Oriental herb beverage composition for pet and method thereof | |
KR20150040392A (en) | undiluted stevia liquid and the berages, and its manufacturing method | |
KR101578070B1 (en) | Health supplementing food for enhancing hair restoration, alleviating and improving hair loss, adjusting blood sugar, alleviating and improving gastrointestinal disorders | |
KR100419185B1 (en) | Healty food composition for obesity control | |
CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
CN103920140B (en) | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation | |
Adeoye et al. | Feeding behaviour, weight gain and blood sugar of male wistar rats fed on a high-calorie diet and vegetables | |
Okon et al. | Nutraceutical potentials of wild and neglected edible leafy vegetables (Sterculia tragacantha and Sesamum indicum) in Akwa Ibom State-Nigeria | |
CN103181557A (en) | Nutritious food with slimming function and preparation method thereof | |
Bakhru | Indian spices & condiments as natural healers | |
CN105815738A (en) | Product assisting in lowering blood glucose and preparation method thereof | |
Subramaniam | A survey of medicinal plants from Chitheri hills in Dharmapuri district, Tamilnadu | |
CN105191859A (en) | Production method of low-cholesterol potassium-rich carotene-rich egg | |
CN109662317A (en) | A kind of composition and its application method for stomach conditioning health | |
Reddy et al. | Ethnobotanical Information of Medicinal Plants Used for Diabetes Mellitus in Seshachalam Biosphere Reserve, Andhra Pradesh, India | |
KR20190069904A (en) | Tablet-type composition for preventing and relieving hangover, and protecting hepatic caused by alcohol containing medical herbs | |
CN106942659A (en) | A kind of preparation method of dioecism momordica root health care buccal tablets | |
US20130058995A1 (en) | Composition and method for weight reduction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee | ||
G170 | Publication of correction |